I. Szabolcs et al., APOPLEXY OF A PITUITARY MACROADENOMA AS A SEVERE COMPLICATION OF PREOPERATIVE THYROTROPIN-RELEASING-HORMONE (TRH) TESTING, EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 105(4), 1997, pp. 234-236
The case history of a 54-year-old male suffering from pituitary macroa
denoma with suprasellar extension is reported. A TRH-test with 200 mu
g i.v. was followed by severe headache and vomiting after 60', and by
development of ophthalmoplegia on the following day. Hyperdens patches
on the CT scan showed haemorrhage into the tumor. A chromophobic aden
oma with macroscopic and histological signs of haemorrhage was removed
via the transsphenoidal route. In the postoperative period the ophtha
lmoplegia gradually disappeared but central hypoadrenia and hypothyroi
dism occurred. This is the second case in the literature showing that
TRH alone and in a low dose may cause pituitary tumor apoplexy. It is
concluded that TRH-testing is a risk for the patient with pituitary ap
oplexy. If, due to the size of the tumor the patients have to be opera
ted on in any case, and the test is not of essential diagnostic value,
the TRH-test should be done only in selected cases. Its use in the po
stoperative evaluation however is without risk for the patients.